Oct 15, 2018

Chugai Expresses its Support for the “Japan Climate Action Summit Declaration”

TOKYO, October 15, 2018 -- Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced its support for the “Japan Climate Action Summit Declaration”, which was announced on October 12, 2018 by the Japan Climate Initiative (JCI), a networking organization for measures addressing climate change. The Declaration is available in Japanese at JCI’s website.

The JCI is a flexible network of companies, local governments, institutions, NGOs and other non-state members that proactively aim to realize a decarbonized society through the implementation of measures addressing climate change. Having CDP Worldwide-Japan, the Renewable Energy Institute and the World Wide Fund for Nature (WWF Japan) as secretariat organizations, the JCI aims at joining the front line of global trend for decarbonization from Japan. Chugai joined JCI as a founding member when it was established on July 6, 2018.

Today’s announcement of the “Japan Climate Action Summit Declaration” reinforces the JCI’s commitment to lead and accelerate decarbonization efforts in Japan and across the globe. It also supports the goals described in the Paris Agreement, which aim to hold the increase in the global average temperature to well below 2 °C and pursue efforts to limit the temperature increase to 1.5 °C. Additional highlights include the JCI’s determination to make Japan a global leading center for the decarbonization movement. Chugai announced its support for the Declaration based on the company’s common goals and approval of the JCI’s intentions.

Chugai conducts its business activities to fulfill its mission of benefiting the medical community and human health around the world. In recent years, interest has grown in using environmental, social and governance (ESG) metrics to assess non-financial corporate value. As a company which engages in business related to health, an important issue in society, Chugai recognizes that ESG is inextricably linked to the continuous and long-term fulfillment of the company’s mission. Therefore, Chugai will continue to promote long-term and sustainable Company-wide efforts to help protect the global environment.


  • For Media
  • Chugai Pharmaceutical Co., Ltd.
  • Media Relations Group, Corporate Communications Dept.,
  • Tomoko Shimizu
  • Tel: +81-3-3273-0881
  • E-mail: pr@chugai-pharm.co.jp
  • For Investors
  • Chugai Pharmaceutical Co., Ltd.
  • Investor Relations Group, Corporate Communications Dept.,
  • Toshiya Sasai
  • Tel: +81-3-3273-0554
  • E-mail: ir@chugai-pharm.co.jp
  • Like
  • Post
  • LINE it!
  • E-mail
Back to top